A Summary of Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

Saved in:
Bibliographic Details
Published inArteriosclerosis, thrombosis, and vascular biology Vol. 24; no. 8; pp. 1329 - 1330
Main Authors Grundy, Scott M, Cleeman, James I, Merz, C Noel Bairey, Brewer, H Bryan, Clark, Luther T, Hunninghake, Donald B, Pasternak, Richard C, Smith, Sidney C, Stone, Neil J
Format Journal Article
LanguageEnglish
Published United States American Heart Association, Inc 01.08.2004
Subjects
Anticholesteremic Agents - therapeutic use
Cholesterol, LDL - blood
Clinical Trials as Topic - statistics & numerical data
Coronary Disease - epidemiology
Coronary Disease - prevention & control
Goals
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Hypercholesterolemia - drug therapy
Hypercholesterolemia - epidemiology
Practice Guidelines as Topic
Randomized Controlled Trials as Topic - statistics & numerical data
Risk
Triglycerides - blood
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:1079-5642
1524-4636
DOI:10.1161/01.ATV.0000139012.45265.e0